BEST-CLI试验:非索引肢体踝上截肢率高
本研究分析BEST-CLI试验中1400例慢性肢体威胁性缺血患者,评估非索引肢体踝上截肢的发生率及危险因素。随访期间6.9%患者发生非索引肢体踝上截肢,与终末期肾病、较低的非索引肢体趾压和较年轻年龄独立相关,且这些患者非索引肢体血运重建和索引肢体截肢率显著更高。
要点
- 非索引肢体踝上截肢发生率为6.9%,终末期肾病患者风险显著增加。
- 非索引肢体趾压较低和较年轻年龄与非索引肢体截肢独立相关。
- 发生非索引肢体截肢者常需非索引肢体血运重建和索引肢体截肢。
核心结论
- BEST-CLI试验中非索引肢体踝上截肢与终末期肾病、较低非索引肢体趾压和较年轻年龄相关。
- 非索引肢体截肢患者中较高比例接受非索引肢体血运重建和索引肢体踝上截肢。
研究设计与样本
- 对BEST-CLI试验中1400例参与者进行回顾性分析。
- 主要结局为非索引肢体踝上截肢,采用多变量Cox回归识别相关因素。
主要发现
- 非索引肢体截肢者更年轻(63 vs 67岁;P < .001)、糖尿病(81.3% vs 66.1%;P = .002)、终末期肾病(28.1% vs 9.0%;P < .001)和较低非索引肢体趾压(52 ± 31.6 mm Hg vs 64 ± 32.2 mm Hg;P = .015)。
- 非索引肢体截肢者非索引肢体血运重建率更高(90.6% vs 17.7%;HR 10.95;95%CI 8.56-14.01;P < .001),索引肢体踝上截肢率更高(45.8% vs 12.1%;HR 4.62;95%CI 3.28-6.50;P < .001)。
- 3年全因死亡率无显著差异(26.2% vs 28.2%;HR 1.28;95%CI 0.92-1.77;P = .15)。
- 多变量Cox回归中,非索引肢体踝上截肢与较年轻年龄(HR 0.94;95%CI 0.89-1.00;P = .047)、终末期肾病(HR 10.73;95%CI 3.09-37.30;P < .001)和较低非索引肢体趾压(HR 0.98;95%CI 0.97-1.00;P = .049)相关。
临床怎么用
- 对慢性肢体威胁性缺血患者应评估双下肢,尤其终末期肾病等高危人群。
- 非索引肢体趾压较低者需加强预防策略以降低截肢风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the incidence and risk factors associated with nonindex limb (NIL) above-ankle amputations among BEST-CLI (Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia) trial participants. BACKGROUND: BEST-CLI compared endovascular therapy and infrainguinal bypass for patients with chronic limb-threatening ischemia (CLTI), focusing on the ipsilateral index limb. However, it is recognized that peripheral artery disease (PAD) can also impact the contralateral limb. We sought to evaluate the incidence and risk factors associated with NIL above-ankle amputations among BEST-CLI trial participants. METHODS: We analyzed data from 1400 participants in BEST-CLI. The primary outcome was the occurrence of above-ankle amputation in the NIL. Secondary outcomes included revascularization in the NIL, above-ankle amputation in the index limb, and mortality at the 3-year follow-up for the cohort that underwent NIL above-ankle amputations. Multivariable Cox regression was used to identify factors associated with above-ankle amputation in the NIL. RESULTS: Ninety-six participants (6.9%) underwent a NIL above-ankle amputation over the course of follow-up. These patients were more likely to be younger at enrollment (63 vs 67 years; P < .001), have diabetes mellitus (81.3% vs 66.1%; P = .002), end-stage renal disease (ESRD) (28.1% vs 9.0%; P < .001), and lower NIL toe pressure at enrollment (52 ± 31.6 mm Hg vs 64 ± 32.2 mm Hg; P = .015). Participants who underwent NIL amputation had significantly higher rates of open or endovascular revascularization in NIL (90.6% vs 17.7%; hazard ratio [HR], 10.95; 95% CI, 8.56-14.01; P < .001) and above-ankle amputations in the index limb (45.8% vs 12.1%; HR, 4.62; 95% CI, 3.28-6.50; P < .001). On 3-year Kaplan-Meier analysis, there was no significant difference in all-cause mortality between participants with and without NIL amputations (26.2% vs 28.2%; HR, 1.28; 95% CI, 0.92-1.77; P = .15). In multivariable Cox regression, NIL above-ankle amputation was associated with younger age at baseline (HR, 0.94; 95% CI, 0.89-1.00; P = .047), ESRD (HR, 10.73; 95% CI, 3.09-37.30; P < .001), and lower NIL toe pressure at baseline (HR, 0.98; 95% CI, 0.97-1.00; P = .049). CONCLUSIONS: In the BEST-CLI trial cohort, NIL above-ankle amputations were associated with ESRD, lower NIL toe pressure, and younger age. A significant proportion of patients who had a NIL above-ankle amputation also underwent revascularization of NIL and an index limb above-ankle amputation within 3 years. Our findings highlight the need for targeted preventive strategies that focus on both limbs in high-risk populations to enhance limb preservation after revascularization for peripheral artery disease.
引用
- Tan TW, Dansey KD, Farber A, et al. High rates of nonindex limb amputation in the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial. J Vasc Surg. 2025. PMID: 41242623. doi:10.1016/j.jvs.2025.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。